717.90EUR+0.17%Mkt Cap: 80.43B $P/E: 20.591d ago
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammator…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap80.43B $
Enterprise Value70.84B $
Revenue (TTM)16.89B $
Gross Profit13.31B $
Net Income (TTM)4.90B $
Revenue/Share163.38 USD
Last Price717.90 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees15.4K
CountryDE
SectorHealthcare
IndustryBiotechnology
ISINUS75886F1075
Valuation
P/E (Trailing)20.59
P/E (Forward)—
PEG1.35
EV/EBITDA13.86
EV/Revenue4.20
P/S4.68
P/B2.57
EPS (TTM)34.93
EPS (Forward)—
52W Range
702.0087% of range720.20
52W High720.20 EUR
52W Low702.00 EUR
Profitability
Gross Margin85.35%
Oper. Margin33.11%
EBITDA Margin30.27%
Profit Margin31.41%
ROE14.41%
ROA11.11%
Growth
Revenue Growth16.70%
Earnings Growth-4.50%
Cash Flow & Leverage
Operating CF5.41B $
CapEx (TTM)1.32B $
FCF Margin19.73%
FCF Yield4.14%
Net Debt-5.75B $
Net Debt/EBITDA-1.12
Balance Sheet
Debt/Equity0.09
Current Ratio3.33
Quick Ratio2.63
Book Value/Sh274.05 EUR
Cash/Share80.06 EUR
Dividends
Fwd Div Rate3.300 EUR
Trail. Div Rate3.640 EUR
Div. Yield0.48%
5Y Avg Yield—
Payout Ratio6.83%
Ex-Div DateAug 18, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.101.14M
Float95.78M
Insiders2.08%
Institutions93.45%
Technical
SMA 50589.36 (+21.8%)
SMA 200623.24 (+15.2%)
Beta0.19
S&P 52W Chg20.80%
Avg Vol (30d)12
Avg Vol (10d)24
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—